Disease on EC 2.9.1.1 - L-seryl-tRNASec selenium transferase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Hepatitis
Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis.
Hepatitis
Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis.
Hepatitis
Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen.
Hepatitis
Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques.
Hepatitis
Identification of T cell epitopes on soluble liver antigen in Chinese patients with auto-immune hepatitis.
Hepatitis
Significance of antibodies to soluble liver antigen/liver pancreas: a large French study.
Hepatitis
[A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis]
Hepatitis A
False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection.
Hepatitis A
Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis: A PRISMA-Compliant Meta-Analysis.
Hepatitis, Autoimmune
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
Hepatitis, Autoimmune
Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis.
Hepatitis, Autoimmune
Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study.
Hepatitis, Autoimmune
Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.
Hepatitis, Autoimmune
Antibodies to soluble liver antigen: specific marker of autoimmune hepatitis.
Hepatitis, Autoimmune
Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.
Hepatitis, Autoimmune
Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis.
Hepatitis, Autoimmune
Discrimination of autoimmune hepatitis: autoantibody typing and beyond.
Hepatitis, Autoimmune
False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection.
Hepatitis, Autoimmune
Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.
Hepatitis, Autoimmune
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.
Hepatitis, Autoimmune
Immunoreactivity to cytokeratin 8/18 in patients with soluble liver antigen (SLA) positive autoimmune hepatitis (AIH type 3) is not sufficient for diagnostic use.
Hepatitis, Autoimmune
Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis.
Hepatitis, Autoimmune
Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis.
Hepatitis, Autoimmune
Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis: A PRISMA-Compliant Meta-Analysis.
Hepatitis, Autoimmune
Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis.
Hepatitis, Autoimmune
Study of nonstandard auto-antibodies as prognostic markers in auto immune hepatitis in children.
Hepatitis, Autoimmune
Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis.
Hepatitis, Autoimmune
[A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis]
Hepatitis, Autoimmune
[The clinical laboratory in the diagnosis of autoimmune liver diseases]
Hepatitis, Chronic
Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.
Hepatitis, Chronic
Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen.
Hepatitis, Chronic
Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques.
Liver Cirrhosis, Biliary
Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques.
Liver Cirrhosis, Biliary
Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.
Liver Diseases
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
Liver Diseases
Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study.
Liver Diseases
Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.
Liver Diseases
Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.
Nervous System Diseases
Selenium homeostasis and antioxidant selenoproteins in brain: Implications for disorders in the central nervous system.
Nervous System Diseases
Structural basis for early-onset neurological disorders caused by mutations in human selenocysteine synthase.
html completed